The antiviral activity of 17 polyhydroxycarboxylates derived from phenolic compounds was evaluated against herpesviruses and HIV. When present during virus adsorption several of the polymers exhibited potent activity against herpes simplex virus type 1 (HSV-1), HSV-2, thymidine kinase deficient HSV-1, human cytomegalovirus (HCMV) and HIV-1 and HIV-2 at concentrations that were not toxic to the host cells. A close correlation was found between the 50% inhibitory concentrations of the polyhydroxycarboxylates against HCMV-induced cytopathicity, their inhibitory effect on the expression of HCMV-specific immediate early antigens and their inhibitory effects on HCMV adsorption to the cells. The antiviral activity of the phenolic polymers was dependent on the presence of a sufficient number of carboxylic groups. The mechanism of antiviral action of the polyhydroxycarboxylates can thus be ascribed to inhibition of virus adsorption. This type of compound may have potential in a vaginal gel to prevent sexual transmission of HSV and HIV.
BabaMSnoeckRPauwelsR & De ClercqE (1988a). Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrobial Agents and Chemotherapy32: 1742–1745.
2.
BabaMPauwelsRBalzariniJArnoutJDesmyterJ & De ClercqE (1988b). Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proceedings of the National Academy of Science USA85: 6132–6136.
3.
BourneNBernsteinDIIrelandJSonderfanAJProfyAT & StanberryLR (1999) .The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. Journal of Infectious Diseases180: 203–205.
4.
GreenheadPHayesPWattsPSLaingKGGriffinGE & ShattockRJ (2000). Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. Journal of Virology74: 5577–5586.
5.
HelbigBKlöckingR & WutzlerP (1997). Anti-herpes simplex virus type 1 activity of humic acid-like polymers and their o-diphenolic starting compounds. Antiviral Chemistry & Chemotherapy8: 265–273.
6.
IkedaSNeytsJYamamotoNMurrerBTheobaldBBossardGHensonGAbramsMPickerD & De ClercqE (1993). In vitro activity of a novel series of polyoxosilicotungstates against human myxo-, herpes- and retroviruses. Antiviral Chemistry & Chemotherapy4: 253–262.
7.
IkedaSNeytsJVermaSWickramasingheAMohanP & De ClercqE (1994). In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion. Antimicrobial Agents and Chemotherapy38: 256–259.
8.
KlöckingR & SprössigM (1975). Wirkung von Ammoniumhumat auf einige Virus-Zell-Systeme. Z. Allgem. Mikrobiologie15: 25–30.
9.
KlöckingRSprössigMWutzlerPThielK-D & HelbigB (1983). Antiviral wirksame Huminsäuren und huminsäureähnliche Polymere. Zeitschrift für Physiotherapie35: 95–101.
10.
Lüscher-MattliM & GlückR (1990). Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza replication in vivo. Antiviral Research14: 39–50.
11.
Lüscher-MattliM (2000). Polyanions — A lost chance in the fight against HIV and other virus diseases?Antiviral Chemistry & Chemotherapy11: 249–259.
12.
NakashimaHYoshidaOBabaMDe ClercqE & YamamotoN (1989). Anti-HIV activity of dextran sulphate as determined under different experimental conditions. Antiviral Research11: 233–246.
13.
NeytsJSnoeckRScholsDBalzariniJEskoJDVan SchepdaelA & De ClercqE (1992a). Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology189: 48–58.
14.
NeytsJSnoeckRWutzlerPCushmanMKlöckingRHelbigBWangP & De ClercqE (1992b). Poly(hydroxy)carboxylates as selective inhibitors of cytomegalovirus and herpes simplex virus replication. Antiviral Chemistry & Chemotherapy3: 215–222.
15.
NeytsJ & De ClercqE (1995). Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: Impact on the search for vaginal microbicides with anti-HIV activity. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology10: 8–12.
16.
NeytsJReymenDLetourneurDJozefonviczJScholsDEsteJAndreiGMcKennaPWitvrouwMIkedaSClementsJ & De ClercqE (1995). Differential antiviral activity of derivatized dextrans. Biochemical Pharmacology50: 743–751.
17.
NeytsJKristmundsdottirTDe ClercqE & ThormarH (2000). Hydrogels containing monocaprin prevent intravaginal and intracutaneous infections with HSV-2 in mice: Impact on the search for vaginal microbicides. Journal of Medical Virology61: 107–110.
18.
SchnitzerM & KhanSU (1972). Humic substances in the environment. New York: Marcel Dekker.
19.
ScholsDDe ClercqEBalzariniJBabaMWitvrouwMHosoyaMAndreiGSnoeckRNeytsJPauwelsRNagyMGyörgyi-EdelenyiMacHovichRHorvathILöwM & GörögS (1990). Sulphated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena- and retroviruses. Antiviral Chemistry & Chemotherapy1: 233–240.
20.
ScholsDWutzlerPKlöckingRHelbigB & De ClercqE (1991). Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication. Journal of Acquired Immune Deficiency Syndromes4: 677–685.
21.
ScholsDPauwelsRWitvrouwMDesmyterJ & De ClercqE (1992). Differential activity of polyanionic compounds and castanospermine against HIV replication and HIV-induced syncytium formation depending on virus strain and cell type. Antiviral Chemistry & Chemotherapy3: 23–29.
22.
StaffordMKCainDRosensteinIFontaineEAMcClureMFlanaganAMSmithJRTaylor-RobinsonDWeberJ & KitchenVS (1997). A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel: A novel potential intravaginal virucide. Journal of Acquired Immune Deficiency Syndromes Human Retrovirology14: 213–218.
23.
ThielK-DKlöckingR & HelbigB (1976). In vitro studies of the antiviral activity of enzymatically oxidized o-diphenolic compounds against herpes simplex virus type 1 and type 2. Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A234: 159–169.
24.
ThielK-DKlöckingRSchweizerH & SprössigM (1977). In vitro studies of the antiviral activity of ammonium humate against herpes simplex virus type 1 and type 2. Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A239: 304–321.
Van DammeLWrightADepraetereKRosensteinIPoulterVandersmissen LMcKinlayMVan DyckEWeberJProfyALagaM & KitchenV (2000). A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive woman. Sexually Transmitted Infections76: 126–130.
27.
WeberJNunnAO'ConnorTJeffriesDKitchenVMcCormackSStottJAlmondNStoneA & DarbyshireJ (2001). “Chemical condomes” for the prevention of HIV infection: Evaluation of novel agents against SHIV 89.6PDin vitro and in vivo. AIDS15: 1563–1568.
28.
WitvrouwMEsteJAMateuQuinones MEReymenDAndreiGSnoeckRIkedaSPauwelsRBianchiniVittori NDesmyterJ & De ClercqE (1994). Activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped viruses. Antiviral Chemistry & Chemotherapy5: 297–303.
